|
|
Volumn 36, Issue 9, 2004, Pages 2671-2674
|
|
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: Preliminary results of an open prospective study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DOSE RESPONSE;
DRUG DOSE REDUCTION;
FEMALE;
FOLLOW UP;
GLOMERULUS FILTRATION RATE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
LIVER TRANSPLANTATION;
LOW DRUG DOSE;
MALE;
MEAN ARTERIAL PRESSURE;
PRIORITY JOURNAL;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
AGED;
CALCINEURIN;
CARDIOVASCULAR DISEASES;
CREATININE;
DIASTOLE;
DRUG THERAPY, COMBINATION;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
INFANT, NEWBORN;
KIDNEY FUNCTION TESTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
SURVIVORS;
SYSTOLE;
TACROLIMUS;
|
|
EID: 11144249899
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.10.008 Document Type: Article |
|
Times cited : (33)
|
|
References (10)
|
